Citalopram hydrobromide and Abnormal behavior - a phase IV clinical study of FDA data

Summary:

Abnormal behavior is reported as a side effect among people who take Citalopram hydrobromide (citalopram hydrobromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Levothyroxine Sodium, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Abnormal behavior when taking Citalopram hydrobromide. It is created by eHealthMe based on reports of 32,819 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,878 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,365 drugs and 1,947 conditions by eHealthMe. Check the latest studies of Abnormal behavior.

On Jul, 07, 2026

32,819 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 220 people (0.67%) have Abnormal behavior.

Could Citalopram hydrobromide cause Abnormal behavior?

Among these 220 people:

How long have people been on Citalopram hydrobromide when they have Abnormal behavior? *

Click here to view more results

What is the gender of people who have Abnormal behavior when taking Citalopram hydrobromide? *

Click here to view

What is the age of people who have Abnormal behavior when taking Citalopram hydrobromide? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and have Abnormal behavior?

- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Citalopram hydrobromide:

Citalopram hydrobromide (36,878 reports)

Abnormal behavior treatments and more:

Abnormal behavior (51,307 reports)

How severe was Abnormal behavior and when was it recovered:

Abnormal behavior in Citalopram hydrobromide

Expand to all the drugs that have ingredients of citalopram hydrobromide:

Abnormal behavior and drugs with ingredients of citalopram hydrobromide (845 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal behavior:

Abnormal behavior (1,365 drugs)

Browse all the conditions that are associated with Abnormal behavior:

Abnormal behavior (1,947 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.